EGCG: The antioxidant powerhouse in lung cancer management and chemotherapy enhancement
Authors:
- Amit SehgalASAmit Sehgal
- Majaz Ahmad BhatMBMajaz Ahmad Bhat
- Deeksha DograDDDeeksha Dogra
- Suman RawatSRSuman Rawat
- Sunil Kumar DhatwaliaSDSunil Kumar Dhatwalia
Open Access
- 20 October 2023
- journal article
- research article
- Published by Elsevier in Advances in Redox Research
- Vol. 9
Abstract
No abstract availableKeywords
Funding Information
- Department of Science and Technology, Ministry of Science and Technology, India
This publication has 76 references indexed in Scilit:
- Lung cancer stem cells: Progress and prospectsCancer Letters, 2013
- Combination of Low Concentration of (−)-Epigallocatechin Gallate (EGCG) and Curcumin Strongly Suppresses the Growth of Non-Small Cell Lung Cancer in Vitro and in Vivo through Causing Cell Cycle ArrestInternational Journal of Molecular Sciences, 2013
- Role of Ku70 and Bax in epigallocatechin-3-gallate-induced apoptosis of A549 cells in vivoOncology Letters, 2012
- Different fatty acid metabolism effects of (−)-Epigallocatechin-3-Gallate and C75 in Adenocarcinoma lung cancerBMC Cancer, 2012
- Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1Carcinogenesis, 2011
- Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not?Nature Reviews Clinical Oncology, 2011
- Oxidative stress, inflammation, and cancer: How are they linked?Free Radical Biology and Medicine, 2010
- Pro-oxidative activities and dose–response relationship of (−)-epigallocatechin-3-gallate in the inhibition of lung cancer cell growth: a comparative study in vivo and in vitroCarcinogenesis, 2010
- Hepatotoxicity of high oral dose (−)-epigallocatechin-3-gallate in miceFood and Chemical Toxicology, 2010
- N-Acetylcysteine enhances the lung cancer inhibitory effect of epigallocatechin-3-gallate and forms a new adductFree Radical Biology and Medicine, 2008